GlobeNewswire Inc.··Portnoy Law FirmAquestive Faces Class Action Over Anaphylm Drug Approval Misstatements
Portnoy Law Firm files class action against Aquestive Therapeutics for allegedly misleading investors about Anaphylm drug approval prospects, citing undisclosed FDA deficiencies.
AQSTsecurities fraudclass action lawsuit